As of June 10, 2025, Neurobo Pharmaceuticals Inc (NRBO) reports a Graham Number of 2.66.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Neurobo Pharmaceuticals Inc's Graham Number
Over recent years, Neurobo Pharmaceuticals Inc's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2023-12-31 | 2.66 |
| 2022-12-31 | 2.66 |
This trend highlights how Neurobo Pharmaceuticals Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Neurobo Pharmaceuticals Inc's Graham Number to Peers
To better understand Neurobo Pharmaceuticals Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Neurobo Pharmaceuticals Inc (NRBO) | 2.66 |
| Regeneron Pharmaceuticals Inc (REGN) | 500.00 |
| Moderna Inc (MRNA) | 157.32 |
| Vertex Pharmaceuticals Inc (VRTX) | 146.93 |
| Merrimack Pharmaceuticals Inc (MACK) | 67.60 |
| Diffusion Pharmaceuticals Inc (DFFN) | 67.49 |
Compared to its competitors, Neurobo Pharmaceuticals Inc's Graham Number is about average compared to peers, reflecting standard fundamental metrics for the industry.